Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVA22007 in dry eye
NCT00739349Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Aug 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine 2% ophthalmic solution in dry eye syndrome (DED), sponsored by Santen Pharmaceutical. Started Aug 2008; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00739349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739349.